понедельник, 29 августа 2016 г.

Danbury's MannKind continues work on EpiPen alternative

Danbury's MannKind continues work on EpiPen alternative


Matthew Pfeffer, Corporate Vice President and CFO of MannKind Corporation, speaks at its annual stockholders meeting on Thursday, May 21, 2015, in Danbury, Conn. Matthew Pfeffer, Corporate Vice President and CFO of MannKind Corporation, speaks at its annual stockholders meeting on Thursday, May 21, 2015, in Danbury, Conn.



from Biotech News